CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-31 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,480 | 0 | ||
| 2023-10-31 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,752 | 0 | ||
| 2023-09-01 | Cordova Ashley Chief Financial Officer | Sale | −883 | $21.82 | $19K | 99,650 |
| 2023-09-01 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −294 | $21.82 | $6K | 209,825 |
| 2023-09-01 | Shah Pritesh Chief Growth Officer | Sale | −273 | $21.82 | $6K | 124,893 |
| 2023-08-02 | Cordova Ashley Chief Financial Officer | Sale | −1,144 | $30.25 | $35K | 100,533 |
| 2023-06-30 | Weinberg Uri Chief Innovation Officer | Grant or award | +305 | $35.28 | $11K | 89,349 |
| 2023-06-30 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +366 | $35.28 | $13K | 210,119 |
| 2023-06-30 | Shah Pritesh Chief Growth Officer | Grant or award | +367 | $35.28 | $13K | 125,166 |
| 2023-06-30 | Burke William Patrick Chief Human Resources Officer | Grant or award | +357 | $35.28 | $13K | 66,447 |
| 2023-06-30 | Ben Arye Barak General Counsel | Grant or award | +288 | $35.28 | $10K | 35,195 |
| 2023-06-30 | Cordova Ashley Chief Financial Officer | Grant or award | +367 | $35.28 | $13K | 101,677 |
| 2023-06-30 | Danziger Asaf Chief Executive Officer | Grant or award | +367 | $35.28 | $13K | 13,989 |
| 2023-06-07 | VERNON W ANTHONY Director | Grant or award | +3,853 | 165,797 | ||
| 2023-06-07 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +6,277 | 6,277 | ||
| 2023-06-07 | Scannell Timothy J Director | Grant or award | +3,853 | 3,928 | ||
| 2023-06-07 | Scannell Timothy J Director | Grant or award · Stock Option (Right to Buy) | +6,277 | 6,277 | ||
| 2023-06-07 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +12,554 | 12,554 | ||
| 2023-06-07 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +12,554 | 12,554 | ||
| 2023-06-07 | LEUNG GABRIEL Director | Grant or award | +3,853 | 79,139 |
Page 13 of 20 · 399 trades